Launched: June 1, 2020
Length: 45 minutes
Presenters:
Dr Rebecca Ann C. Auer, MD, MSc, FRCSC
Dr Christopher Bredeson, MD MSc FRCPC
Dr Paul Wheatly-Price, BSc, MBChB, FRCP (UK), MD
Dr Jean-Marc Bourque, MD, MScPH, FRCPC
Webinar overview: In this webinar, a panel of expert doctors answer common questions about the impact of COVID-19 on cancer treatment across Canada. For example, what is the status of clinical trials? When can loved ones accompany someone receiving treatment? And how will the healthcare system help if someone receiving treatment contracts COVID- 19?
Presenters
Dr Rebecca Ann C. Auer
Scientific Director, Cancer Therapeutics Program, Ottawa Hospital Research Institute
Surgical Oncologist, Ottawa Hospital
Associate Professor, Department of Surgery and the Department of Biochemistry, Microbiology and Immunology, University of Ottawa
Dr Christopher Bredeson
Head, Malignant Hematology and SCT, Ottawa Hospital
Professor of Medicine, University of Ottawa
Dr Paul Wheatly-Price
Medical Oncologist, Ottawa Hospital Cancer Centre
President of Lung Cancer Canada
Associate Professor, Department of Medicine, University of Ottawa
Dr Jean-Marc Bourque
Radiation Oncologist and Assistant Professor, University of Ottawa
Adjunct professor, McGill University
